Anna Gann, MD
Internal Medicine · Huntsville, ALNPI 1033796685
Payments from drug & device makers
Across 86 payments — averaging $15.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$270
- Novo Nordisk$214
- Phathom Pharmaceuticals, Inc.$92
- AstraZeneca$84
- Exact Sciences$81
- Amgen$75
- plus $516 from 14 others
What the payments were for
- Food & beverage$1,332100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 19 | $270 |
| Novo Nordisk | 17 | $214 |
| Phathom Pharmaceuticals, Inc. | 9 | $92 |
| AstraZeneca | 5 | $84 |
| Exact Sciences | 5 | $81 |
| Amgen | 5 | $75 |
| Bayer | 4 | $72 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $65 |
| Inspire Medical Systems, Inc. | 2 | $55 |
| Boehringer Ingelheim | 3 | $52 |
| Pfizer | 2 | $42 |
| Dynavax Technologies Corporation | 2 | $36 |
| Merck | 2 | $34 |
| GSK | 2 | $34 |
| AbbVie | 1 | $27 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| United Therapeutics Corporation | 1 | $16 |
How this compares
$1,332 in reported general payments places this provider in the 65th percentile of 1,533 internal medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 19 | $776 |
| Atorvastatin Calcium | 43 | $288 |
| Amlodipine Besylate | 29 | $169 |
| Omeprazole | 12 | $168 |
| Levothyroxine Sodium | 20 | $149 |
| Lisinopril | 28 | $130 |
| Losartan Potassium | 12 | $112 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Huntsville
- Saadat AnsariHuntsville$2.1M
- Tiffany Schwasinger-SchmidtHuntsville$787K
- John ClarkHuntsville$756K
- Palak ShahHuntsville$49K
- Joseph HastieHuntsville$44K
- Harry StuddardMobile$12.9M
- Almena FreeAnniston$12.7M
- Hayes WilliamsVestavia$10.4M
- David DeatkineBirmingham$8M
- James SullivanBirmingham$6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.